University of Miami Sylvester Comprehensive Cancer Center

 

University of Miami Sylvester Comprehensive Cancer Center
R

Improved Outcomes With Ramucirumab & Docetaxel in mNSCLC After Failure of IO: REVEL Trial

By University of Miami Sylvester Comprehensive Cancer Center FEATURING Richa Dawar
By University of Miami Sylvester Comprehensive Cancer Center FEATURING Richa Dawar
337 views
July 15, 2021
1 Comment
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
Lung
22:57
Total Health

Lung Cancer Screening - Best of Lung 2023

Feat. C. Olazagasti
26:53
University of Miami Sylvester Comprehensive Cancer Center

Lung Cancer Screening & Prevention

Feat. R. Dawar
15:34
University of Miami Sylvester Comprehensive Cancer Center

Improved Outcomes With Ramucirumab & Docetaxel in mNSCLC After F…

Feat. R. Dawar